General Surgical Innovations/Dexterity Surgical, Inc.
This article was originally published in The Gray Sheet
Executive Summary
GSI's Spacemaker balloon dissector products will be offered by Dexterity Surgical's 100-rep sales force under a distribution contract announced May 26. GSI hopes to capture share in the hernia and stress urinary incontinence repair markets, capitalizing on its successful court injunction of sales of Guidant's PDB1000, PDB2, ExtraView and VasoView devices, manufactured by its Origin Medsystems subsidiary ("The Gray Sheet" April 19, p. 22). Dexterity previously distributed the Origin products
You may also be interested in...
Tyco Makes Space For General Surgical Innovations Alongside USSC
Tyco International's $100 mil. stock-swap acquisition of minimally invasive balloon dissection device maker General Surgical Innovations is expected to close within the next 90 days, GSI estimates.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.